EyePoint (EYPT) Assets Average (2011 - 2026)
EyePoint (EYPT) reported Assets Average of $326.1 million for Q1 2026, down 16.49% on a YoY basis from $390.5 million in Q1 2025, and up 5.93% sequentially from $307.8 million in Q4 2025.
EyePoint (EYPT) Assets Average (2011 - 2026) Analysis & Trends
EyePoint (EYPT) has 16 years of Assets Average data on file, last reported at $326.1 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average fell 16.49% year-over-year to $326.1 million; the trailing twelve-month figure through Mar 2026 stood at $326.1 million (down 16.49% YoY), and the FY2025 full-year result was $391.2 million, up 1.14% from the prior year.
- Assets Average advanced to $326.1 million in Q1 2026, from $307.8 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $390.5 million in Q1 2025 to a low of $165.1 million in Q2 2023.
- A 5-year average of $273.7 million and a median of $276.4 million in 2025 frame the typical range for Assets Average.
- Across the five-year window, Assets Average tumbled 34.06% in 2023 and soared 104.34% in 2024, its largest moves.
- Tracing EYPT's Assets Average over 5 years: stood at $200.4 million in 2022, then advanced by 28.53% to $257.6 million in 2023, then jumped by 39.62% to $359.7 million in 2024, then dropped by 14.41% to $307.8 million in 2025, then gained by 5.93% to $326.1 million in 2026.
- Business Quant data shows EYPT's Assets Average at $326.1 million in Q1 2026, $307.8 million in Q4 2025, and $276.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | 326.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 326.11 Mn |
| Dec 31, 2025 | 307.85 Mn |
| Sep 30, 2025 | 276.42 Mn |
| Jun 30, 2025 | 331.86 Mn |
| Mar 31, 2025 | 390.51 Mn |
| Dec 31, 2024 | 359.69 Mn |
| Sep 30, 2024 | 312.58 Mn |
| Jun 30, 2024 | 326.75 Mn |
| Mar 31, 2024 | 342.22 Mn |
| Dec 31, 2023 | 257.61 Mn |
| Sep 30, 2023 | 167.85 Mn |
| Jun 30, 2023 | 165.12 Mn |
| Mar 31, 2023 | 167.47 Mn |
| Dec 31, 2022 | 200.42 Mn |
| Sep 30, 2022 | 226.96 Mn |
| Jun 30, 2022 | 238.99 Mn |
| Mar 31, 2022 | 253.96 Mn |
| Dec 31, 2021 | 215.81 Mn |
| Sep 30, 2021 | 173.54 Mn |
| Jun 30, 2021 | 182.98 Mn |